• Special Issue Topic

    Comorbidities in rheumatoid arthritis

    Submission Deadline: September 01, 2023

    Guest Editor

    Prof. Joan M. Nolla E-Mail

    Head of Rheumatology Department, Bellvitge University Hospital. Barcelona; Professor of Medicine, Department of Clinical Sciences, University of Barcelona, Barcelona, Spain

    Research Keywords: Treatment of immune-mediated rheumatic diseases, comorbidities in rheumatoid arthritis, sarcopenia, osteoporosis comorbidities in rheumatoid arthritis


    About the Special Issue

    Rheumatoid arthritis (RA) constitutes the paradigm of highly complex rheumatic disease.

    In recent years, with the advent of disease-modifying, biologic, and synthetic antirheumatic drugs, there has been a veritable revolution in the treatment of the disease. The possibility of interfering with the signals that produce and amplify inflammatory phenomena makes it possible to significantly attenuate clinical manifestations and even, on occasions, achieve remission of the process.

    Parallel to drug development, there has been a remarkable change in the RA care model. Outcome measures have been established and it is possible to predefine therapeutic objectives.

    At the same time that RA activity has been limited, awareness of comorbid conditions has clearly increased. It is now unanimously considered that the clinician should pay special attention to the control of infections, cardiovascular diseases, and osteoporosis. Beyond these traditional processes, the spectrum of associated disorders is increasingly broad (fatigue, nutritional disturbances, sarcopenia, neuropsychiatric disorders, among others). Its impact on the clinical course of the disease is highly relevant.

    In this issue we make an approximation to the comorbidities of RA.

    Keywords: Rheumatoid arthritis, comorbidities

    Published Articles

    Open Access
    Editorial
    Sarcopenia, a hidden comorbidity of established rheumatoid arthritis
    This editorial, “Sarcopenia: a hidden comorbidity of established rheumatoid arthritis” emphasizes the critical role of addressing comorbidities in rheumatoid arthritis (RA) management, focusing particularly on the clinical imp [...] Read more.
    Joan M. Nolla
    Published: July 19, 2024 Explor Musculoskeletal Dis. 2024;2:293–299
    DOI: https://doi.org/10.37349/emd.2024.00057
    View:668
    Download:14
    Times Cited: 0
    Open Access
    Systematic Review
    Obesity in rheumatoid arthritis: impact on response to biologic therapies
    Background: We performed a service evaluation of local patients with rheumatoid arthritis (RA) treated with biologic or targeted systemic disease-modifying anti-rheumatic drug (b/ts)DMARDs to see [...] Read more.
    Zehra Irshad, Nicola J. Gullick
    Published: June 12, 2024 Explor Musculoskeletal Dis. 2024;2:216–234
    DOI: https://doi.org/10.37349/emd.2024.00050
    View:564
    Download:17
    Times Cited: 0
    Open Access
    Perspective
    Redefining comorbidity understanding in rheumatoid arthritis through novel approaches using real-world data
    Rheumatoid arthritis (RA) is a prevalent chronic disease that is associated with numerous comorbidities. Accurate assessment of these coexisting conditions, as reported by clinicians, is critical fo [...] Read more.
    Diego Benavent, Chamaida Plasencia-Rodríguez
    Published: February 01, 2024 Explor Musculoskeletal Dis. 2024;2:40–48
    DOI: https://doi.org/10.37349/emd.2024.00032
    View:1043
    Download:17
    Times Cited: 0
    Open Access
    Review
    Rheumatoid arthritis and cardiovascular comorbidities
    Rheumatoid arthritis (RA) is the most common rheumatologic disease characterized by inflammation with a definite relationship with heart disease. Impaired immunity, chronic inflammation, genetic sus [...] Read more.
    Uğur Özkan ... Murat Birtane
    Published: December 06, 2023 Explor Musculoskeletal Dis. 2023;1:264–288
    DOI: https://doi.org/10.37349/emd.2023.00028
    View:1697
    Download:48
    Open Access
    Original Article
    Impact of disease activity on patient-reported subjective cognitive decline in patients with rheumatoid arthritis
    Aim: To evaluate the association of disease activity with patient-reported subjective cognitive decline (SCD) in patients with rheumatoid arthritis (RA) stratified by age. Methods: A cross- [...] Read more.
    Ozlem Pala ... Joel M. Kremer
    Published: December 05, 2023 Explor Musculoskeletal Dis. 2023;1:228–240
    DOI: https://doi.org/10.37349/emd.2023.00025
    View:1123
    Download:14
    Times Cited: 0
    Open Access
    Perspective
    Nutritional problems in rheumatoid arthritis patients with temporomandibular joint involvement
    Rheumatoid arthritis (RA) is an inflammatory arthritis that affects synovial joints, and it is not surprising that the temporomandibular joint (TMJ), a synovial joint, is also affected. However, TMJ [...] Read more.
    Manolya Ilhanli, Ilker Ilhanli
    Published: October 31, 2023 Explor Musculoskeletal Dis. 2023;1:180–185
    DOI: https://doi.org/10.37349/emd.2023.00020
    View:1079
    Download:20
    Times Cited: 0
    Open Access
    Review
    Interstitial lung disease in patients with rheumatoid arthritis: a narrative review
    Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease of unknown origin. Although it mainly affects joints, it can have extra-articular manifestations, with the lung being one  [...] Read more.
    Gloria Candelas Rodríguez, Virginia Villaverde
    Published: October 20, 2023 Explor Musculoskeletal Dis. 2023;1:128–142
    DOI: https://doi.org/10.37349/emd.2023.00017
    View:2245
    Download:76
    Times Cited: 0